Evidence map›Paper›PMID 37979041›Full record

ArticleInternational urogynecology journal2024

Patient perspectives on treatment and prevention of recurrent urinary tract infections: a focus group study.

Surbhi Agrawal, Heidi Harvie, Lorraine Flick, Ravi B Parikh, Uduak U Andy, Lily Arya

Abstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Surbhi AgrawalUrogynecology, Perelman School of Medicine, University of Pennsylvania, 3737 Market Street, 12th floor, Philadelphia, PA, 19104, USA. surbhi.agrawal@pennmedicine.upenn.edu.ORCID 0000-0002-1155-491X
Heidi HarvieUrogynecology, Perelman School of Medicine, University of Pennsylvania, 3737 Market Street, 12th floor, Philadelphia, PA, 19104, USA.
Lorraine FlickUrogynecology, Perelman School of Medicine, University of Pennsylvania, 3737 Market Street, 12th floor, Philadelphia, PA, 19104, USA.
Ravi B ParikhDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Uduak U Andy *Urogynecology, Perelman School of Medicine, University of Pennsylvania, 3737 Market Street, 12th floor, Philadelphia, PA, 19104, USA.
Lily Arya *Urogynecology, Perelman School of Medicine, University of Pennsylvania, 3737 Market Street, 12th floor, Philadelphia, PA, 19104, USA.
University of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisWe sought to understand factors that are important to patients for the management of recurrent urinary tract infections (UTI) during both an acute episode and for the prevention of future episodes.

methodsThis was a qualitative study with focus groups in women with recurrent UTIs. Participants filled out information about prior recurrent UTI treatment and the Belief about Medicines Questionnaire (BMQ). Each 90-minute focus group was moderated by a nonphysician psychologist. Line-by-line coding of each transcript by three independent physicians was used to develop emergent concepts and themes using Grounded Theory methodology.

resultsTwenty-six women participated in six focus groups. The average age of participants was 62 years and 77% were post-menopausal. All women had already tried multiple prevention strategies for their recurrent UTIs. The average BMQ-specific scores indicated a net positive attitude toward medicines specifically prescribed for recurrent UTI prevention. Several themes emerged from the focus groups. First, patients wanted providers to acknowledge the high burden imposed by frequent interactions with the health care system for the management of recurrent UTI. Second, patients wanted earlier access to providers knowledgeable in the management of this condition. Third, patients wanted to self-manage their condition through a structured treatment plan with support from their providers. Finally, patients wanted greater emphasis on education and prevention strategies to reduce their antibiotic intake.

conclusionsPatients with recurrent UTI want more efficient workflows, a framework that promotes self-management in partnership with their providers, and a greater emphasis on prevention.

Indexed as

Anti-Bacterial AgentsUrinary Tract InfectionsEducational StatusFemaleFocus GroupsHumansMiddle AgedQualitative ResearchAnti-Bacterial AgentsAntimicrobial stewardshipHealth-related quality of lifePatient empowermentPreventative medicineSelf-managementUrinary tract infections, prevention, and control

Identifiers

PMID37979041
OpenAlexW4388796045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.